Techniques for repairing focal articular cartilage defects are evolving fro
m methods that induce a local stimulation of fibrocartilaginous repair to m
ethods that will lead to a hyaline articular cartilage repair. Mosaicplasty
and autologous chondrocyte implantation are examples of the latter. A tiss
ue engineered hyaline cartilage implant that could be used off the self wou
ld minimize the morbidity of these techniques. However, there are significa
nt questions that still need to be resolved before such tissue-engineered i
mplants will be practical. Principally among these is the question of what
is the ideal matrix for such an implant, particularly from the standpoint o
f the best material and architecture. Second, what is the ideal cell source
to use with these implants. A third major unknown is what is the most idea
l way to use growth factors to enhance the repair. As these issues are reso
lved, the prospects of a tissue engineered cartilage replacement will advan
ce from theory to practice.